Search
Business Practice
View More
Business
Development
Legal
Policy
Practice
Regulatory
Business
Development
Legal
Policy
Practice
Regulatory
News
Media
All Videos
Insights
Interviews
Peer Exchange
Podcasts
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Clinical
Dermatology
Endocrinology
Gastroenterology
Legal
Neurology
Oncology
Ophthalmology
Rare Disease
Rheumatology
Dermatology
Endocrinology
Gastroenterology
Legal
Neurology
Oncology
Ophthalmology
Rare Disease
Rheumatology
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
CME/CE
Resources
Authors
Biosimilar Resources
Polls
Authors
Biosimilar Resources
Polls
Subscribe
Search
Business Practice
See All >
Business
Development
Legal
Policy
Practice
Regulatory
Global Perspective on the Effect of Biosimilars
EP 1: Comparison of Biologics to Biosimilars Versus Generics
October 10th 2018
EP 2: The BPCIA and the Naming of Biosimilars
October 10th 2018
EP 3: The Approval Process for Biosimilars
October 10th 2018
EP 4: Considerations for Approving Generics Versus Biosimilars
October 10th 2018
EP 5: Interchangeability and Postmarketing Pharmacovigilance of Biosimilars
October 10th 2018
EP 6: Experience Prescribing Biosimilars Versus Biologics
October 10th 2018
EP 7: The Impact of Access to Biosimilars
October 10th 2018
EP 8: US and EU Biosimilar Pricing and Stakeholder Education
October 10th 2018
EP 9: Formulary Approval and Challenges for Payers
October 10th 2018
EP 10: Prescribing Biosimilars and Educating Patients and Physicians
October 10th 2018
EP 11: The Influence of Biosimilars in Cancer Care
October 10th 2018
EP 12: Biosimilars in the Pipeline and Disease Management
October 10th 2018
EP 13: Outlook on the Future of Biosimilars
October 10th 2018
Next >>